An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer (Q46352943)
Jump to navigation
Jump to search
scientific article published on 20 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer |
scientific article published on 20 September 2008 |
Statements
1 reference
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer (English)
1 reference
F Caponigro
1 reference
D Lacombe
1 reference
C Twelves
1 reference
J Bauer
1 reference
A-S Govaerts
1 reference
S Marréaud
1 reference
A Milano
1 reference
A Anthoney
1 reference
20 September 2008
1 reference
1 reference
45
1 reference
1
1 reference
48-55
1 reference
Identifiers
1 reference
1 reference